Gene Editing Clinical Trials

Access comprehensive information on gene editing and gene therapy clinical trials. Find opportunities for sickle cell disease, cancer, muscular dystrophy, and more.

1153

Active Clinical Trials

Trials by Condition

Understanding Clinical Trials

What Are Clinical Trials?

Clinical trials are research studies that test new medical approaches in people. Gene editing and gene therapy trials evaluate whether these treatments are safe and effective for various genetic conditions.

Clinical Trial Phases

Gene therapy clinical trials typically progress through several phases:

  • Phase 1: Tests safety and dosage in a small group (20-80 people)
  • Phase 2: Evaluates effectiveness and side effects in more people (100-300)
  • Phase 3: Confirms effectiveness, monitors side effects, and compares to standard treatments (1,000-3,000 people)
  • Phase 4: Post-marketing studies to gather additional information on risks, benefits, and optimal use

How to Find the Right Trial

Finding a suitable clinical trial involves several considerations:

  • Your specific diagnosis and medical history
  • Trial eligibility criteria (age, disease stage, prior treatments)
  • Trial location and travel requirements
  • Phase of the trial and potential risks
  • Time commitment and follow-up requirements

Participant Rights and Protections

All clinical trials must follow strict ethical guidelines. Participants have the right to:

  • Receive detailed information about the trial before enrolling
  • Ask questions at any time
  • Leave the trial at any point without penalty
  • Have their privacy protected
  • Receive appropriate medical care throughout the trial

Next Steps

Browse trials by condition above to find studies relevant to your situation. Each trial listing includes detailed eligibility criteria, locations, and contact information. Always consult with your healthcare provider before pursuing enrollment in a clinical trial.

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026